PAH biomarkers for human health risk assessment: A review of the state-of-the-art

Cadernos de Saude Publica

Volumn 24, Issue SUPPL.4, 2008, Pages

  Franco, Sérgio Silveira ^a   Nardocci, Adelaide Cássia ^a   Günther, Wanda Maria Risso ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 52949121757     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/s0102-311x2008001600009     Document Type: Review

References (64)

1. International Programme on Chemical Safety, World Health Organization. Biomarkers and risk assessment: validity and validation. Geneva: World Health Organization; 2001. (Environmental Health Criteria, 222).
2. van der Oost R, Beyer J, Vermeulen NPE. Fish bioaccumulation and biomarkers in environmental risk assessment: a review. Environ Toxicol Pharmacol 2003; 13:57-149.
3. Jacob J, Seidel A. Biomonitoring of polycyclic aromatic hydrocarbons in human urine. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 778:31-47.
4. Bonassi S, Neri M, Puntoni R. Validation of biomarkers as early predictors of disease. Mutat Res 2001; 480:349-58.
5. International Programme on Chemical Safety, World Health Organization. Selected non-hetero-cyclic polycyclic aromatic hydrocarbons. Geneva: World Health Organization; 1998. (Environmental Health Criteria, 202).
6. Office of Air Quality Planning and Standards, U. S. Environmental Protection Agency. Handbook for air toxics emission inventory development. v. I: stationary sources. Research Triangle Park: U. S. Environmental Protection Agency; 1998. (EPA-454/B-98-002).
7. Agency for Toxic Substances and Disease Registry. Toxicological profile for polycyclic aromatic hydrocarbons. Atlanta: Agency for Toxic Substances and Disease Registry; 1995.
8. Pereira Netto AD, Krauss TM, Cunha IF, Rego ECP. Polycyclic aromatic hydrocarbons levels in street dust in the central area of Niterói City, RJ, Brazil. Water Air Soil Pollut 2006; 176:57-67.
9. Pereira Netto AD, Barreto R P, Moreira JC, Arbilla G. PAHs in diurnal and nocturnal samples of total suspended particulate in a highly trafficked area of Rio de Janeiro City, Brazil. Bull Environ Contam Toxicol 2005; 75:1004-11.
10. Pereira Netto AD, Cunha IF, Muniz FC, Rego ECP. Polycyclic aromatic hydrocarbons in street dust of Niterói City, RJ, Brazil. Bull Environ Contam Toxicol 2004; 72:829-35.
11. Burchiel SW, Luster MI. Signaling by environmental polycyclic aromatic hydrocarbons in human lymphocytes. Clin Immunol 2001; 98:2-10.
12. Boström CE, Gerde P, Hanberg A, Jernström B, Johansson C, Kyrklund T, et al. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 2002; 110:451-88.
13. Godschalk RW, Van Schooten FJ, Bartsch H. A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. J Biochem Mol Biol 2003; 36:1-11.
14. Ehrenberg L, Granath F, Törnqvist E. Macromolecular adducts as biomarkers of exposure to environmental mutagens in human populations. Environ Health Perspect 1996; 104:423-8.
15. Brandt HC, Watson WP. Monitoring human occupational and environmental exposures to polycyclic aromatic compounds. Ann Occup Hyg 2003; 47:349-78.
16. Jongeneelen FJ. Methods for routine biological monitoring of carcinogenic PAH-mixtures. Sci Total Environ 1997; 199:141-9.
17. Sorensen MAH, Moller P, Hertel O, Jensen SS, Vinzents P, Knudsen LE, et al. Linking exposure to environmental pollutants with biological effects. Mutat Res 2003; 544:255-71.
18. Viau C, Lafontaine M, Payan JP. Creatinine normalization in biological monitoring revisited: the case of 1-hydroxypyrene. Int Arch Occup Environ Health 2004; 77:177-85.
19. Tsai PJ, Shih TS, Chen HL, Lee WJ, Lai CH, Liou SH. Urinary 1-hydroxypyrene as an indicator for assessing the exposures of booth attendants of a highway toll station to polycyclic aromatic hydrocarbons. Environ Sci Technol 2004; 38:56-61.
20. Siwinska E, Mielzynska D, Kapka L. Association between urinary 1-hydroxypyrene and genotoxic effects in coke oven workers. Occup Environ Med 2004; 61:1-10.
21. Hansen AM, Wallin H, Binderup ML, Dybdahl M, Autrup H, Loft S, et al. Urinary 1-hydroxypyrene and mutagenicity in bus drivers and mail carriers exposed to urban air pollution in Denmark. Mutat Res 2004; 557:7-17.
22. Wünsch Filho V, Gattás GJF. Biomarcadores moleculares em câncer: implicações para a pesquisa epidemiológica e a saúde pública. Cad Saúde Pública 2001; 17:467-80.
23. Peluso M, Ceppi M, Munnia A, Puntoni R, Parodi S. Analysis of 13 32P-postlabeling studies on occupational Cohorts exposed to air pollution. Am J Epidemiol 2001; 153:546-58.
24. Phillips DH, Schoket B, Hewer A, Bailey E, Kostic S, Vincze I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int J Cancer 1990; 46:569-75.
25. Herbert R, Marcus M, Wolff MS, Perera F P, Andrews L, Godbold JH, et al. Detection of adducts of de-oxyribonucleic acid in white blood cells of roofers by 32P-postlabeling. Relationship of adduct levels to measures of polycyclic aromatic hydrocarbons. Scand J Work Environ Health 1990; 16:135-43.
26. De Flora S, Izotti A, D'Agostini F, Rossi GA, Balansky RM. Pulmonary alveolar macrophages in molecular epidemiology and chemoprevention of cancer. Environ Health Perspect 1993; 99:249-52.
27. Besaratinia A, Maas LM, Brouwer EM, Kleinjans JC, Van Schooten FJ. Comparison between smokingrelated DNA adduct analysis in induced sputum and peripheral blood lymphocytes. Carcino-genesis 2000; 21:1335-40.
28. Dallinga JW, Pachen DM, Wijnhoven SW, Breedijk A, van't Veer L, Wigbout G, et al. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure. Cancer Epidemiol Biomark-ers Prev 1998; 7:571-7.
29. Schoket B, Papp G, Levay K, Mrackova G, Kadlubar FF, Vincze I. Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure. Mutat Res 2001; 482:57-69.
30. Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 2004; 149:309-34.
31. Schulte PA, Pereira FP. Molecular epidemiology principles and practices. San Diego: Academic Press; 1993.
32. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, et al. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res 2000; 463:111-72.
33. Bonassi S, Abbondandolo A, Camurri L, Dal Prá A, De Ferrari M, Degrassi F, et al. Are chromosome aberrations in circulating lymphocytes predictive of a future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cy-togenet 1995; 79:133-5.
34. Smerhovsky Z, Landa K, Rössner P, Brabec M, Zudova Z, Hola N, et al. Risk of cancer in an oc-cupationally exposed cohort with increased level of chromosomal aberrations. Environ Health Perspect 2001; 109:41-5.
35. Au WW, Oh HY, Grady J, Salama SA, Heo MY. Usefulness of genetic susceptibility and biomarkers for evaluation of environmental health risk. Environ Mol Mut 2001; 37:215-25.
36. Garte S. Metabolic susceptibility genes as cancer risk factors: time for a reassessment. Cancer Epidemiol Biomarkers Prev 2001; 10:1233-7.
37. Strange RC, Jones, PW, Fryer, AA. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 2000; 112/113:357-63.
38. Knudsen LB, Norppa H, Gamborg MG, Nielsen PS, Okkels H, Soll-Johanning H, et al. Chromosomal aberrations induced by urban air pollution in humans: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidemiol Biomarkers Prev 1999; 8:303-10.
39. Brescia G, Celotti L, Clonfero E, Neumann HG, Forni A, Foá V, et al. The influence of cytochrome P450 lAl and glutathione S-transferase M1 genotypes on biomarker levels in coke-oven workers. Arch Toxicol 1999; 73:431-9.
40. Šrám R, Birkova B, Rössner P, Rubes J, Topinka J, Dejmek J. Adverse reproductive outcomes from exposure to environmental mutagens. Mutat Res 1999; 428:203-15.
41. Ichiba M, Hagmar L, Rannug A, Högstedt B, Alexandrie A-K, Carstensen U, et al. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYPlA1 and GST in chimney sweeps. Carcinogen-esis 1994; 15:13-52.
42. Hung RJ, Boffetta P, Brockmöller J, Butkiewicz D, Cascorbi I, Clapper ML, et al. CYPlA1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 2003; 24:875-82.
43. Schulte PA. Opportunities for the development and use of biomarkers. Toxicol Lett 1995; 77:25-9.
44. Jekel JF, Elmore JG, Katz DL. Epidemiologia, bioestatística e medicina preventiva. Porto Alegre: Editora Artmed; 2002.
45. Szklo M, Nieto FJ. Epidemiology: beyond the basis. Gaithesburg: Aspen Publication; 2000.
46. Symanski E, Greeson NMH. Assessment of variability in biomonitoring data using a large database of biological measures of exposure. AIHA J 2002; 63:390-401.
47. Suter GW. Ecological risk assessment. Boca Raton: Lewis Publishers; 1993.
48. Dubé M, Munkittrick K. Integration of effects-based and stressor-based approaches into a holistic framework for cumulative effects assessment in aquatic ecosystems. Human and Ecological Risk Assessment 2001; 7:247-58.
49. Moore MN, Depledge MH, Readman JW, Paul Leonard DR. An integrated biomarker-based strategy for ecotoxicological evaluation of risk in environmental management. Mutat Res 2004; 552:247-68.
50. National Academy of Sciences. Risk assessment in the federal government: managing the process. Washington DC: National Academy Press; 1983.
51. Bonassi S, Au WW. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat Res 2002; 511:73-86.
52. Bonassi S, Ugolini D, Kirsch-Volders M, Stromberg U, Vermeulen R, Tucker JD. Human population studies with cytogenetic biomarkers: Review of the literature and future prospectives. Environ Mol Mutagen 2005; 45:258-70.
53. Tucker JD. Sensitivity, specificity, and persistence of chromosome translocations for radiation bio-dosimetry. Mil Med 2002; 167:8-9.
54. Hayes RB, Smith CO, Huang WY, Read Y, Kopp WC. Whole blood cryopreservation in epidemiological studies. Cancer Epidemiol Biomarkers Prev 2002; 11:1496-8.
55. Beck JC, Beiswanger CM, John EM, Satariano E, West D. Successful transformation of cryopre-served lymphocytes: a resource for epidemiologi-cal studies. Cancer Epidemiol Biomarkers Prev 2001; 10:551-4.
56. Cheng L, Wang LE, Spitz MR, Wei Q. Cryopreserving whole blood for functional assays using viable lymphocytes in molecular epidemiology studies. Cancer Lett 2001; 166:155-63.
57. Smerhovsky Z, Landa K, Rössner P, Juzova D, Brabec M, Zudova Z, et al. Increased risk of cancer in radon-exposed miners with elevated frequency of chromosomal aberrations. Mutat Res 2002; 514:165-76.
58. Toraason M, Albertini R, Bayard S, Bigbee W, Blair A, Boffetta P, et al. Applying new biotechnologies to the study of occupational cancer: a workshop summary. Environ Health Perspect 2004; 112:413-6.
59. Bonassi S, Znaor A, Norppa H, Hagmar L. Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective. Cytogenet Genome Res 2004; 104:376-82.
60. Neri M, Ugolini D, Bonassi S, Fucic A, Holland N, Knudsen LE, et al. Children's exposure to environmental pollutants and biomarkers of genetic damage. II. Results of a comprehensive literature search and meta-analysis. Mutat Res 2006; 612: 14-39.
61. Neri M, Bonassi S, Knudsen LE, Sram RJ, Holland N, Ugolini D, et al. Children's exposure to environmental pollutants and biomarkers of genetic damage I. Overview and critical issues. Mutation Research 2006; 612:1-13.
62. Steinemann AC. Human exposure, health hazards, and environmental regulations. Environ Impact Assess Rev 2004; 24:695-710.
63. Lopes WA, Andrade JB. Fontes, formação, reatividade e quantificação de hidrocarbonetos policí-clicos aromáticos (HPA) na atmosfera. Quím Nova 1996; 19:497-516.
64. Pereira Netto AD, Moreira JC, Dias AEXO, Arbilla G, Ferreira LFV, Oliveira AS, et al. Avaliação da contaminação humana por hidrocarbonetos policícli-cos aromáticos (HPAs) e seus derivados nitrados (NHPAs): uma revisão metodológica. Quím Nova 2000; 23:765-73.